You are here

Clinical utility and cost-effectiveness of genomic sequencing for epilepsy

Description 
Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of genetic testing that has the advantage of being able to screen all the genes in a person. Currently it is mainly being used for research purposes. The purpose of this prospective study is to find out whether genomic sequencing offers value for money when used in the clinical setting to help diagnose people with epilepsy.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
epilepsy, sequencing
School 
Central Clinical School
Available options 
PhD/Doctorate
Masters by Research
Honours
BMedSc(Hons)
Time commitment 
Full-time
Physical location 
AMREP
Co-supervisors 
Dr 
Alison Anderson

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.